11.24.2015 - By Sean P. Kane, PharmD; Khyati Patel, PharmD
In this episode, we discuss two new anti-diabetic medications: empagliflozin (Jardiance) and the EMPA-REG OUTCOME trial as well as dulaglutide (Trulicity), a new GLP1 agonist.